To include your compound in the COVID-19 Resource Center, submit it here.

212Pb-TCMC-Trastuzumab: Phase I started

Areva Med LLC, Bethesda, Md.
Product: 212Pb-TCMC-Trastuzumab
Business: Cancer
Molecular target: NA
Description:

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE